Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) has shared an announcement.
Chaoju Eye Care Holdings has proposed a final ordinary cash dividend of HK$0.2423 per share for the financial year ended 31 December 2025, underscoring management’s confidence in the group’s performance and cash generation. Subject to shareholder approval on 12 May 2026, the dividend will be paid on 3 June 2026, with shares trading ex-dividend on 14 May and a record date of 20 May, providing income-focused investors with clearer visibility on the company’s capital return timetable.
The announcement also reiterates the company’s current board composition, led by Chairman and executive director Zhang Bozhou alongside a mix of executive, non-executive and independent non-executive directors. This governance structure may reassure stakeholders about oversight as the group balances dividend payouts with ongoing investment needs in its eye care operations and regional growth strategy.
The most recent analyst rating on (HK:2219) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.
More about Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Limited operates in the eye care and ophthalmic services sector, providing medical treatments and related services to patients in Hong Kong and mainland China. The company focuses on specialized eye health solutions and is listed on the Hong Kong Stock Exchange under stock code 02219.
Average Trading Volume: 423,460
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.83B
See more data about 2219 stock on TipRanks’ Stock Analysis page.